Daphne Zohar is a co-founder and the Chief Executive Officer of PureTech (PRTC.L) and a member of the Board. A successful entrepreneur, Ms. Zohar created PureTech, assembling a leading team to help implement her vision for the Company, and attracting over $450 million to the Company and its operating companies.

Ms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including BioWorld, MIT's Technology Review, the Boston Globe, and Scientific American. She sits on the boards of PureTech, the Sync Project, Akili Interactive Labs, Follica, Karuna and Tal.

She also sits on the Technology Development Fund Advisory Board at Children's Hospital Boston and is an Editorial Advisor to Xconomy, a national news company. 

Fund's investment verticals: life sciences, therapeutics, medical devices, metabolism, pharmaceuticals, neuroscience, drug delivery, immunology and platform technologies.